NCT07352475 Reasoning Enrichment With Feedback From IA in NEphrology Trial
| NCT ID | NCT07352475 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Diagnosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-11-20 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-11-20 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn how artificial intelligence (AI) may help doctors make diagnoses in kidney medicine. The researchers want to know whether an AI tool called a large language model (LLM) can help doctors choose the correct diagnosis more often and feel more confident in their answers. Before starting the study, the research team tested several AI models and chose one of the best performers, a GPT-5-class model set to use high reasoning effort. The main questions this study aims to answer are: 1. Do doctors make more correct diagnoses when they can see AI suggestions? 2. Does seeing AI suggestions change how confident doctors feel about their diagnosis? Researchers will compare doctors who receive AI suggestions with doctors who do not receive AI suggestions to see how the AI affects accuracy, confidence, and decision-making. Participants will complete up to 10 online clinical cases. For each case, they will: 1. Read a short medical scenario 2. Suggest up to three possible diagnoses (If in the AI group) Review the AI's suggestions and decide whether to change their answer The study will also look at how long participants take to answer each case and how the AI's performance compares to the human answers.
Eligibility Criteria
Inclusion Criteria: Adults aged 18 years or older. Able to read and answer clinical vignettes in English or French. Access to a computer or smartphone with an internet connection. Provides informed consent online. Participants are expected to have at least basic medical training (e.g., medical students, residents, fellows, or practicing clinicians), although no formal verification is required. Exclusion Criteria: Individuals under 18 years of age. Inability to complete online study procedures. Prior involvement in the design, development, or evaluation of the AI system used in this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07352475 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diagnosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07352475 currently recruiting?
Yes, NCT07352475 is actively recruiting participants. Contact the research team at raphael.bentegeac@univ-lille.fr for enrollment information.
Where is the NCT07352475 trial being conducted?
This trial is being conducted at Lille, France.
Who is sponsoring the NCT07352475 clinical trial?
NCT07352475 is sponsored by University Hospital, Lille. The trial plans to enroll 100 participants.